A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)

OBJECTIVE: To evaluate efficacy of S-1 (tegafur/gimeracil/oteracil), an active novel fluoropyrimidine, as compared to UFT (tegafur/uracil) as a postoperative adjuvant therapy in patients with node-negative non–small cell lung cancer (NSCLC). METHODS: Eligible patients had undergone complete resectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunitoh, Hideo, Tsuboi, Masahiro, Wakabayashi, Masashi, Okada, Morihito, Suzuki, Kenji, Watanabe, Shun-ichi, Asamura, Hisao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Thoracic: Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390442/
https://www.ncbi.nlm.nih.gov/pubmed/36004301
http://dx.doi.org/10.1016/j.xjon.2020.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390442/
https://www.ncbi.nlm.nih.gov/pubmed/36004301
http://dx.doi.org/10.1016/j.xjon.2020.08.009

Ejemplares similares